TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has granted an aggregate of 1,050,060 incentive stock options to members of its board of directors. 250,060 of the options are exercisable at $0.144 per share for five years from the date of grant and vest immediately, 250,000 of the options are exercisable at $0.14 per share for five years from the date of grant and vest on November 3, 2015, and 550,000 of the options are exercisable at $0.14 per share for five years from the date of grant and vest on December 31, 2015. The grant of options is subject to the provisions of the Company’s Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.
